Member Exclusive
Commerce Unveils AI Chip Curbs, CV Rule Finalized, and Trump Cabinet Picks Signal Tough China Policy
To improve the treatment of Type 1 diabetes in China, Medtronic Inc. is partnering with the National Institute of Hospital Administration, a Chinese think-tank. Medtronic will conduct research projects and help establish pilot sites for the proposed system at as many as 12 regional children’s hospitals and general hospitals in China.